Ειδήσεις: WEDBUSH | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

01/04 11:43 defenseworld.net

The Goldman Sachs Group Issues Positive Forecast for Bicara Therapeutics (NASDAQ:BCAX) Stock Price

Bicara Therapeutics Goldman Sachs price target stock rating market optimism Wedbush

01/04 10:41 defenseworld.net

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Rating of “Moderate Buy” by Analysts

AnaptysBio Moderate Buy Analyst Ratings Price Target Pipeline Clinical Milestones

01/04 10:26 defenseworld.net

Aprea Therapeutics (NASDAQ:APRE) Given Outperform Rating at Wedbush

Aprea Therapeutics APRE analyst ratings Wedbush HC Wainwright Zacks

01/04 10:26 defenseworld.net

Viridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $37.00 at Wedbush

Viridian Therapeutics price target Wedbush Royal Bank of Canada Wall Street Zen outperform rating

01/04 10:16 defenseworld.net

Bicara Therapeutics (NASDAQ:BCAX) Price Target Raised to $42.00 at HC Wainwright

Bicara Therapeutics price target HC Wainwright analyst ratings Citigroup Weiss Ratings

01/04 09:56 defenseworld.net

IDEAYA Biosciences (NASDAQ:IDYA) Receives Outperform Rating from Wedbush

IDEAYA Biosciences IDYA Wedbush Cantor Fitzgerald Wall Street Zen UBS Group

31/03 10:00 defenseworld.net

Opus Genetics (NASDAQ:IRD) Coverage Initiated by Analysts at Cantor Fitzgerald

Opus Genetics Cantor Fitzgerald Wedbush BTIG Weiss Ratings target price

31/03 10:00 defenseworld.net

Uber Technologies (NYSE:UBER) Price Target Lowered to $95.00 at Wells Fargo & Company

Uber price target Wells Fargo Morgan Stanley Benchmark Wedbush

30/03 09:30 defenseworld.net

EIKN (NASDAQ:EIKN) Receives $25.60 Average Price Target from Analysts

EIKN price target analyst ratings Cantor Fitzgerald Wedbush NASDAQ

30/03 09:30 defenseworld.net

EIKN (NASDAQ:EIKN) Receives $25.60 Average Price Target from Analysts

EIKN price target analyst ratings Cantor Fitzgerald Wedbush NASDAQ

Loading...